Identification Of Blood Markers For Asymptomatic Ventricular Dysfunction (IBLOMAVED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01024049

Recruitment Status : Unknown

Verified January 2012 by Institut National de la Santé Et de la Recherche Médicale, France.
Recruitment status was: Recruiting

First Posted : December 2, 2009

Last Update Posted : January 31, 2012

Sponsor:

Information provided by (Responsible Party):

Institut National de la Santé Et de la Recherche Médicale, France

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	December 2012
Estimated Study Completion Date :	December 2012

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Koukoui F, Desmoulin F, Galinier M, Barutaut M, Caubère C, Evaristi MF, Murat G, De Boer R, Berry M, Smih F, Rouet P. The prognostic value of plasma galectin-3 in chronic heart failure patients is maintained when treated with mineralocorticoid receptor antagonists. PLoS One. 2015 Mar 18;10(3):e0119160. doi: 10.1371/journal.pone.0119160. eCollection 2015.

To Top